Valion Bio, Inc. Net Cash Provided by (Used in) Operating Activities, Continuing Operations
Valion Bio, Inc. (VBIO) reported Net Cash Provided by (Used in) Operating Activities, Continuing Operations of -$10.32 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations · last filed 2026-08-14
- Valion Bio, Inc. net cash provided by (used in) operating activities, continuing operations for the quarter ending 2026-06-30 was -$5.27M.
- Valion Bio, Inc. net cash provided by (used in) operating activities, continuing operations for the quarter ending 2026-03-31 was -$5.05M.
- Valion Bio, Inc. net cash provided by (used in) operating activities, continuing operations for the quarter ending 2025-06-30 was -$1.59M.
- Valion Bio, Inc. net cash provided by (used in) operating activities, continuing operations for the quarter ending 2025-03-31 was -$829.00K.
- Valion Bio, Inc. net cash provided by (used in) operating activities, continuing operations for fiscal 2025 was -$6.62M.
- Valion Bio, Inc. net cash provided by (used in) operating activities, continuing operations for fiscal 2024 was -$5.08M.
| Period end | Net Cash Provided by (Used in) Operating Activities, Continuing Operations 3 month | Net Cash Provided by (Used in) Operating Activities, Continuing Operations 6 month | Net Cash Provided by (Used in) Operating Activities, Continuing Operations 12 month |
|---|---|---|---|
| 2026-06-30 | -$5.27M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | -$10.32M 10-Q · filed 2026-08-14 | |
| 2026-03-31 | -$5.05M 10-Q · filed 2026-05-14 | ||
| 2025-12-31 | -$6.62M 10-K · filed 2026-03-30 | ||
| 2025-06-30 | -$1.59M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | -$2.42M 10-Q · filed 2026-08-14 | |
| 2025-03-31 | -$829.00K 10-Q · filed 2026-05-14 | ||
| 2024-12-31 | -$5.08M 10-K · filed 2026-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |
| iBio, Inc. (IBIO) | United States | $0.077B | -2.94 |
| Adicet Bio, Inc. (ACET) | United States | $0.078B | -0.81 |
| Lifevantage Corp (LFVN) | United States | $0.078B | 15.40 |
| Verrica Pharmaceuticals Inc. (VRCA) | United States | $0.076B | -3.39 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |